BUZZ-GW Pharmaceuticals: Positive results from late-stage trial
** Drug developer GW Pharmaceuticals' shares up 22.8 pct, best day in 3 mths and at 9 mth highs, after saying a late-stage trial of its epilepsy drug met its main goal ** Co says its experimental drug Epidiolex reduced the occurence of drop-seizures in patients with Lennox-Gastault syndrom
Read more